Fingerprint
Dive into the research topics of 'A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase Ib/II study of cabozantinib (XL184) with or without erlotinib in patients with non-small cell lung cancer
Heather A. Wakelee, Scott Gettinger, Jeffrey Engelman, Pasi A. Jänne, Howard West, Deepa S. Subramaniam, Joseph Leach, Michael Wax, Yifah Yaron, Dale R. Miles, Primo N. Lara
Research output: Contribution to journal › Article › peer-review
29
Scopus
citations